{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:02:22Z","timestamp":1790798542474,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtha.2026.07.022","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:43:11Z","timestamp":1790797391000},"page":"3450-3452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extended anticoagulation with edoxaban in chronic thromboembolic pulmonary hypertension: reassuring real-world data, but can direct oral anticoagulants systematically replace vitamin K antagonists?"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-3010","authenticated-orcid":false,"given":"Laurent","family":"Bertoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-3666","authenticated-orcid":false,"given":"C\u00e9line","family":"Chapelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.07.022_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtha.2026.07.022_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1378\/chest.81.2.151","article-title":"Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data","volume":"81","author":"Riedel","year":"1982","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.07.022_bib3","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.124.068610","article-title":"Worldwide CTEPH registry: long-term outcomes with pulmonary endarterectomy, balloon pulmonary angioplasty, and medical therapy","volume":"150","author":"Delcroix","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.07.022_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1183\/09031936.00201612","article-title":"Chronic thromboembolic pulmonary hypertension: role of medical therapy","volume":"41","author":"Pepke-Zaba","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtha.2026.07.022_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101240","article-title":"Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH","volume":"68","author":"Escal","year":"2024","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2026.07.022_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.05.003","article-title":"Indications and potential pitfalls of anticoagulants in pulmonary hypertension: would DOACs become a better option than VKAs?","volume":"37","author":"Margelidon-Cozzolino","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2026.07.022_bib7","article-title":"Use of direct anticoagulants in chronic thromboembolic pulmonary hypertension: an anatomopathological study of endarterectomy material","volume":"443","author":"Salibe-Filho","year":"2025","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtha.2026.07.022_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12110","article-title":"Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy","volume":"12","author":"Jeong","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jtha.2026.07.022_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/jth.14649","article-title":"A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension","volume":"18","author":"Bunclark","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.022_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000445122","article-title":"Risk of direct oral anticoagulant bioaccumulation in patients with pulmonary hypertension","volume":"91","author":"Gabriel","year":"2016","journal-title":"Respiration"},{"key":"10.1016\/j.jtha.2026.07.022_bib11","first-page":"PA914","article-title":"Bleeding under anticoagulant therapy in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: incidence and prognostic impact, data from the HEMA-HTP study","volume":"66","author":"Bertoletti","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtha.2026.07.022_bib12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.healun.2022.02.002","article-title":"Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension","volume":"41","author":"Humbert","year":"2022","journal-title":"J Hear Lung Transplant"},{"key":"10.1016\/j.jtha.2026.07.022_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIRCULATIONAHA.123.067528","article-title":"A multicenter, single-blind, randomized, warfarin-controlled trial of edoxaban in patients with chronic thromboembolic pulmonary hypertension: KABUKI trial","volume":"149","author":"Hosokawa","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.07.022_bib15","first-page":"3564","article-title":"Long-term real-world effectiveness and safety of edoxaban in chronic thromboembolic pulmonary hypertension: a nationwide registry study","volume":"24","author":"Hosokawa","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.022_bib14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(24)02842-3","article-title":"Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial","volume":"405","author":"Couturaud","year":"2025","journal-title":"Lancet"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:43:43Z","timestamp":1790797423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626004800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1538783626004800"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.07.022","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended anticoagulation with edoxaban in chronic thromboembolic pulmonary hypertension: reassuring real-world data, but can direct oral anticoagulants systematically replace vitamin K antagonists?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}